Member info
Dr Kristel Harak
Estonia
Working Group(s): Retinal Rare Eye Diseases (WG1), Low Vision Daily Life and Patients Groups (TWG5), Registries & Epidemiology (TWG7), National Integration (TWG9)
Team
Dr Artur Klett
Estonia
Anterior Segment Rare Eye Diseases (WG4), National Integration (TWG9)
Dr Katrin Eerme
Estonia
Pediatric Ophthalmology Rare Diseases (WG3), Retinal Rare Eye Diseases (WG1)
Dr Reili Rebane
Estonia
CPMS & Digital Medecine (TWG10), Pediatric Ophthalmology Rare Diseases (WG3)
Dr Delis Linntam
Estonia
Anterior Segment Rare Eye Diseases (WG4), Retinal Rare Eye Diseases (WG1)
HCP Center
Internationally recognized experts of East-Tallinn Central Hospital Eye Department treat eye disorders in infants, children and adults.
Picture :...
contact
East-Tallinn Central Hospital Eye Clinic, Tallinn, Estonia
Ravi 18
10138 Tallinn
Estonia
Clinical trials
NCT04423718 Active, Not recruiting
Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of High Dose Aflibercept in Patients With Neovascular Age-Related Macular Degeneration
Interventional
NCT04270747 Completed
A Randomized, Double-masked, Phase 3 Study of ABP 938 Efficacy and Safety Compared to Aflibercept (Eylea®) in Subjects With Neovascular Age-related Macular Degeneration
Interventional
NCT02686658 Completed
A Phase 2/3 Randomized, Double-Masked, Controlled Trial to Assess the Safety and Efficacy of Intravitreous Administration of Zimura™ (Anti-C5 Aptamer) in Subjects With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Interventional